http://rdf.ncbi.nlm.nih.gov/pubchem/patent/HU-T58293-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d78cd2835221849f6a74e6349185819 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D219-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D219-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-435 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D219-08 |
| filingDate | 1991-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66ce3cf1368c39511f0ba0010eaea35e http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92b5787456e8665f217e8df37bdfa738 |
| publicationDate | 1992-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | HU-T58293-A |
| titleOfInvention | Process for producing tricyclic heterocyclic compounds and pharmaceutical compositions containing them as active components |
| abstract | The invention relates to tricyclic heterocyclic derivatives, or pharmaceutically-acceptable salts or in vivo hydrolysable esters thereof, which possess anti-cancer activity. The invention also relates to processes for the manufacture of said tricyclic heterocyclic derivatives, to novel pharmaceutical compositions containing them and to the use of said tricyclic heterocyclic derivatives in the manufacture of a medicament for the production of an anti-cancer effect. The invention provides an optionally substituted tricyclic heterocyclic derivative of the formula I <CHEM> wherein A together with the adjacent vinylene group of the 4-oxo-1,4-dihydropyrid-1-yl ring completes a benzene or pyridine ring; R<1> and R<2>, which may be the same or different, each is (1-4C)alkyl or (1-4C)alkoxy; and R<3> is hydrogen, (1-4C)alkyl or (1-4C)alkoxy; or a pharmaceutically-acceptable salt or in vivo hydrolysable ester thereof. |
| priorityDate | 1990-08-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 298.